Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
Propagation of Uncertainty from Systematic Error01:10

Propagation of Uncertainty from Systematic Error

The atomic mass of an element varies due to the relative ratio of its isotopes. A sample's relative proportion of oxygen isotopes influences its average atomic mass. For instance, if we were to measure the atomic mass of oxygen from a sample, the mass would be a weighted average of the isotopic masses of oxygen in that sample. Since a single sample is not likely to perfectly reflect the true atomic mass of oxygen for all the molecules of oxygen on Earth, the mass we obtain from this particular...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Propagation of Uncertainty from Random Error00:59

Propagation of Uncertainty from Random Error

An experiment often consists of more than a single step. In this case, measurements at each step give rise to uncertainty. Because the measurements occur in successive steps, the uncertainty in one step necessarily contributes to that in the subsequent step. As we perform statistical analysis on these types of experiments, we must learn to account for the propagation of uncertainty from one step to the next. The propagation of uncertainty depends on the type of arithmetic operation performed on...
Two-Compartment Open Model: Overview01:05

Two-Compartment Open Model: Overview

Multicompartmental models are crucial tools in pharmacokinetics, providing a framework to understand how drugs move within the body. The two-compartment model is a crucial subtype, segmenting the body into central and peripheral compartments. The central compartment represents areas with high blood flow, such as plasma and highly perfused organs like the kidneys and liver, while the peripheral compartment signifies tissues with lower blood flow, like adipose tissue and muscle tissue.
The...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide association study of yield and related traits in common wheat under salt-stress conditions.

BMC plant biology·2021
Same author

Consistent Estimation of Generalized Linear Models with High Dimensional Predictors via Stepwise Regression.

Entropy (Basel, Switzerland)·2020
Same author

Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by <i>Pseudomonas aeruginosa</i>.

Frontiers in immunology·2020
Same author

Synthesis of High-Water-Resistance Lignin-Phenol Resin Adhesive with Furfural as a Crosslinking Agent.

Polymers·2020
Same author

miR-1246 shuttling from fibroblasts promotes colorectal cancer cell migration.

Neoplasma·2020
Same author

Localized spin-orbit polaron in magnetic Weyl semimetal Co<sub>3</sub>Sn<sub>2</sub>S<sub>2</sub>.

Nature communications·2020

Related Experiment Video

Updated: May 24, 2026

Measuring Microbial Mutation Rates with the Fluctuation Assay
07:44

Measuring Microbial Mutation Rates with the Fluctuation Assay

Published on: November 28, 2019

A Bayesian two-level model for fluctuation assay.

Qi Zheng1

  • 1Department of Epidemiology and Biostatistics, School of Rural Public Health, Texas A&M Health Science Center, College Station, TX 77843, USA. qzheng@srph.tamhsc.edu

Genetica
|March 8, 2012
PubMed
Summary

This study introduces a new Bayesian model to accurately measure microbial mutation rates, overcoming limitations of traditional fluctuation assays. The advanced method provides a more reliable estimation of mutation rates in laboratory settings.

More Related Videos

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Using Three-color Single-molecule FRET to Study the Correlation of Protein Interactions
11:22

Using Three-color Single-molecule FRET to Study the Correlation of Protein Interactions

Published on: January 30, 2018

Related Experiment Videos

Last Updated: May 24, 2026

Measuring Microbial Mutation Rates with the Fluctuation Assay
07:44

Measuring Microbial Mutation Rates with the Fluctuation Assay

Published on: November 28, 2019

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Using Three-color Single-molecule FRET to Study the Correlation of Protein Interactions
11:22

Using Three-color Single-molecule FRET to Study the Correlation of Protein Interactions

Published on: January 30, 2018

Area of Science:

  • Microbiology
  • Statistical Genetics
  • Computational Biology

Background:

  • The fluctuation experiment is a standard laboratory method for determining microbial mutation rates.
  • Current methods rely on assumptions about mutant distribution that limit their applicability.
  • A need exists for more flexible and accurate mutation rate estimation techniques.

Purpose of the Study:

  • To develop a novel Bayesian statistical model for microbial mutation rate estimation.
  • To relax the restrictive distributional assumptions of traditional fluctuation assays.
  • To provide a robust framework for defining an experiment-wide average mutation rate.

Main Methods:

  • Proposed a Bayesian two-level hierarchical model.
  • Utilized a gamma mixture of the Luria-Delbrück distribution.
  • Employed Markov chain Monte Carlo (MCMC) methods for parameter estimation.

Main Results:

  • The proposed model relaxes the common distribution assumption, broadening applicability.
  • The Bayesian approach allows for the definition of an experiment-wide average mutation rate.
  • Demonstrated the model's utility through a detailed analysis of a real fluctuation experiment.

Conclusions:

  • The novel Bayesian model offers a more flexible and accurate approach to measuring microbial mutation rates.
  • The gamma mixture model is a significant advancement for fluctuation assay analysis.
  • This method provides a practical computational tool for mutation rate estimation in research.